Emergent BioSolutions (EBS) Non Operating Income (2011 - 2026)
Emergent BioSolutions (EBS) posted Non Operating Income of -$41.2 million for Q2 2026, down 1520.69% on a QoQ basis from $2.9 million in Q1 2026, and down 123.91% year-over-year from $172.3 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Non Operating Income (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported Non Operating Income for 16 years, with the latest figure at -$41.2 million in Q2 2026.
- On a quarterly basis, Non Operating Income fell 123.91% year-over-year to -$41.2 million in Q2 2026; TTM through Jun 2026 was -$80.0 million, a 195.01% decrease from a year earlier, with the FY2025 full-year figure at -$17.3 million, up 49.42% from the prior year.
- Non Operating Income was -$41.2 million for Q2 2026 at Emergent BioSolutions, down from $2.9 million in the prior quarter.
- The five-year high for Non Operating Income was $77.9 million in Q3 2024, with the low at -$66.3 million in Q2 2024.
- Average Non Operating Income over 5 years is -$8.0 million, with a median of -$15.6 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income surged 495.37% in 2023, then slumped 255.27% in 2024.
- Over 5 years, Non Operating Income stood at -$6.1 million in 2022, then slumped by 75.41% to -$10.7 million in 2023, then plunged by 69.16% to -$18.1 million in 2024, then decreased by 25.97% to -$22.8 million in 2025, then slumped by 80.7% to -$41.2 million in 2026.
- The last three Non Operating Income figures came in at -$41.2 million (Q2 2026), $2.9 million (Q1 2026), and -$22.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | - |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | - |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | -139.24 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | -41.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.20 Mn |
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | -22.80 Mn |
| Sep 30, 2025 | -18.90 Mn |
| Jun 30, 2025 | -18.40 Mn |
| Mar 31, 2025 | 42.80 Mn |
| Dec 31, 2024 | -18.10 Mn |
| Sep 30, 2024 | 77.90 Mn |
| Jun 30, 2024 | -66.30 Mn |
| Mar 31, 2024 | -27.70 Mn |
| Dec 31, 2023 | -10.70 Mn |
| Sep 30, 2023 | -23.80 Mn |
| Jun 30, 2023 | 42.70 Mn |
| Mar 31, 2023 | -13.00 Mn |
| Dec 31, 2022 | -6.10 Mn |
| Sep 30, 2022 | -21.90 Mn |
| Jun 30, 2022 | -10.80 Mn |
| Mar 31, 2022 | -10.20 Mn |
| Dec 31, 2021 | -9.90 Mn |
| Sep 30, 2021 | -10.80 Mn |
API Access
Emergent BioSolutions Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();